Michael J. De Biasi is Director of RVL Pharmaceuticals plc. Currently has a direct ownership of 40,000 shares of RVLP, which is worth approximately $0. The most recent transaction as insider was on Jul 05, 2023, when has been sold 40,000 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40K
0% 3M change
0% 12M change
Total Value Held $0

Michael J. DeBiasi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 05 2023
BUY
Grant, award, or other acquisition
-
40,000 Added 50.0%
40,000 Ordinary Shares
MJD

Michael J. De Biasi

Director
Bridgewater, NJ

Track Institutional and Insider Activities on RVLP

Follow RVL Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVLP shares.

Notify only if

Insider Trading

Get notified when an Rvl Pharmaceuticals PLC insider buys or sells RVLP shares.

Notify only if

News

Receive news related to RVL Pharmaceuticals plc

Track Activities on RVLP